Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Amlodipine besilate; Hydrochlorothiazide; Olmesartan medoxomil
Merck Sharp & Dohme Australia Pty Ltd
Medicine Registered
SEVIKAR ® HCT _Olmesartan medoxomil, amlodipine (as besilate) and hydrochlorothiazide_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about SEVIKAR HCT. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking SEVIKAR HCT against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT SEVIKAR HCT IS USED FOR SEVIKAR HCT is used to treat high blood pressure which is sometimes called hypertension. Everyone has blood pressure. This pressure helps push blood all around your body. Your blood pressure changes at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed. There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems, including stroke, heart disease and kidney failure. _HOW SEVIKAR HCT WORKS_ SEVIKAR HCT contains olmesartan medoxomil, which belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which causes blood vessels to tighten. SEVIKAR HCT blocks the action of angiotensin-II and therefore relaxes your blood vessels. This helps lower your blood pressure. SEVIKAR HCT also contains amlodipine besilate, a calcium channel blocker. This reduces the movement of calcium into the cells of the heart and blood vessels. This also helps to lower blood pressure as it relaxes the blood vessels and increases the supply of blood and oxygen to the heart. SEVIKAR HCT also cont Read the complete document
SEVIKAR HCT PI v1.0 A130920 CCDS ref v4.0 130701 Page 1 PRODUCT INFORMATION SEVIKAR ® HCT FILM COATED TABLETS (olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide) SEVIKAR HCT 20/5/12.5 SEVIKAR HCT 40/5/12.5 SEVIKAR HCT 40/5/25 SEVIKAR HCT 40/10/12.5 SEVIKAR HCT 40/10/25 NAME OF THE MEDICINE OLMESARTAN MEDOXOMIL is chemically described as (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[ [2 '-(1_H_-tetrazol-5-yl) biphenyl-4-yl] methyl] -1_H_- imidazole-5-carboxylate. The empirical formula is C 29 H 30 N 6 O 6 and its molecular weight is 558.6. Its CAS number is 144689-63-4. Its structural formula is: AMLODIPINE BESILATE is a racemic mixture and is chemically described as 3-Ethyl 5-methyl (4_RS_)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5- dicarboxylate benzenesulfonate. The empirical formula is C 20 H 25 CIN 2 O 5 •C 6 H 6 O 3 S and its molecular weight is 567.1. The CAS number is 111470-99-6 and its structural formula is: HYDROCHLOROTHIAZIDE is described chemically as 6-chloro-3,4-dihydro-2_H_-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide. The empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its molecular weight is 297.7 . Its CAS no. is 58-93-5. The structural formula is: SEVIKAR HCT PI v1.0 A130920 CCDS ref v4.0 130701 Page 2 DESCRIPTION OLMESARTAN MEDOXOMIL is a white or almost white crystalline powder. It is practically insoluble in water and slightly soluble in ethanol (96 per cent), practically insoluble in heptane. The pH of a solution (2% w/v) of olmesartan medoxomil in water is 5.6. The dissociation constant (pKa) is 4.3. The partition coefficient Log P is 1.0 at pH 7.0. AMLODIPINE BESILATE is a white or almost white powder, slightly soluble in water and freely soluble in methanol, s Read the complete document